Beth Fand Incollingo

A panel of admissions experts met at Drexel to update high school guidance counselors on changes in the behavior and demographics of students applying to colleges. The changes stem from the test-score-optional trend that is growing across higher education.

One of many short alumni profiles written for Kean University.

Article describing a panel discussion that took place during the annual meeting of the American College of Chest Physicians

Although low-dose CT scans enable the detection of very small lung nodules in individuals who face a high risk of developing lung cancer, it is often impossible to quickly determine whether the lesions are malignant due to their size or location.

Technology designed to enhance the depth of information available when reading a CT scan could reduce the length of follow up in patients with early NSCLC, allowing them to begin treatment sooner, while helping to prevent the performance of unnecessa...

This is an example of conference coverage for a leading nonprofit that informs lung cancer experts.

This coverage of an FDA panel hearing explains the association of certain breast implants with a new form of lymphoma known as BIA-ALCL and an autoimmune condition known as breast implant illness.

I wrote this article, about the results of a phase 3 study testing the PARP inhibitor Lynparza (olaparib) in men with prostate cancer, for an audience of patients, survivors and caregivers.

I wrote this article, about a presentation at the annual meeting of the American Society of Clinical Oncology, for an audience of clinicians.

Part of a series of articles called Accessing Health Care, this piece discusses racial inequities in the liver cancer death rate.

This Q/A explores Dr. Seema Khan's research into the use of tamoxifen gel to help prevent the spread of stage 0 breast cancer.

Jill Reedy, of the National Cancer Institute, explains why and how the nutrition labels on food were recently updated.

Dr. Lifang Hou, of Robert H. Lurie Comprehensive Cancer Center, discusses cancer prevention techniques.

Jonny Imerman, founder of Imerman Angels, told me about his young-adult cancer journey and how it led to the creation of this group that provides free mentoring services by matching survivors with patients facing the same cancer types.

Joshua Mann, of the VHL Alliance, told me about his organization, which supports people with von Hippel-Lindau disease, and discussed an experimental medicine that, if approved by the FDA, will be the first designated specifically to treat those who have the rare condition.

Early in the COVID-19 pandemic, when the concept of telehealth was relatively new to patients with cancer, this article described how the technology could be used to provide oncologic care and follow-up while protecting against the spread of the virus.